Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. From The Nasdaq Stock Market
Acutus Medical | 10-Q: Quarterly report
Earnings Flash (AFIB) ACUTUS MEDICAL Posts Q1 Continuing Operations Revenue $3.6M
Express News | Acutus Medical Reports First Quarter 2024 Financial Results
Acutus Medical 1Q Rev $3.63M >AFIB
Acutus Medical Delisted From Nasdaq Market Due to Non-compliance
Why RingCentral Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Monday's Pre-Market Session
Acutus Medical, Inc. (AFIB) Faces Plummeting Stock Price Amid Delisting Concerns
12 Health Care Stocks Moving In Friday's After-Market Session
Express News | Acutus Medical Shares Are Trading Lower After Nasdaq Notified the Company That It Has Not Regained Compliance With Listing Rule 5550(a)(2)
Express News | Acutus Medical Inc -on April 30, Nasdaq Notified Co That It Has Not Regained Compliance With Listing Rule 5550(a)(2)
Express News | Earlier Announced, Acutus Medical Was Granted EU Patent #3294412 For "Localization System And Method Useful In The Acquisition And Analysis Of Cardiac Information"
Acutus Medical Full Year 2023 Earnings: US$0.41 Loss per Share (Vs US$1.40 Loss in FY 2022)
Acutus Medical GAAP EPS of -$2.81, Revenue of $7.2M
Acutus Medical: Due to Plan to Realign Resources to Support Left-Heart Access Distribution Business and Exit From Electrophysiology Mapping and Ablation Businesses, Co Will No Longer Provide Fincl Guidance >AFIB
Acutus Medical 4Q Rev $2.4M >AFIB
Press Release: Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Monday's After-Market Session
No Data